TSSK2
Testis-specific serine/threonine-protein kinase 2
Also known as: FLJ38613, SPOGA2, STK22B, TSSK2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96PF2
- Gene
- TSSK2
- Ensembl
- ENSG00000206203
- Chromosome
- 22
- Canonical length
- 358 aa
- Protein class
- Enzymes, Predicted membrane proteins
OverviewNCBI Gene
TSSK2 belongs to a family of serine/threonine kinases highly expressed in testis (Hao et al., 2004 [PubMed 15044604]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
358 residues, UniProt reviewed canonical sequence.
>Q96PF2|TSSK2
1 MDDATVLRKK GYIVGINLGK GSYAKVKSAY SERLKFNVAV KIIDRKKTPT DFVERFLPRE
61 MDILATVNHG SIIKTYEIFE TSDGRIYIIM ELGVQGDLLE FIKCQGALHE DVARKMFRQL
121 SSAVKYCHDL DIVHRDLKCE NLLLDKDFNI KLSDFGFSKR CLRDSNGRII LSKTFCGSAA
181 YAAPEVLQSI PYQPKVYDIW SLGVILYIMV CGSMPYDDSD IRKMLRIQKE HRVDFPRSKN
241 LTCECKDLIY RMLQPDVSQR LHIDEILSHS WLQPPKPKAT SSASFKREGE GKYRAECKLD
301 TKTGLRPDHR PDHKLGAKTQ HRLLVVPENE NRMEDRLAET SRAKDHHISG AEVGKASTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSSK2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 181 nTPM
Expression across tissuesHPA
Tissue
- testis: 181 nTPM
- pancreas: 0.5 nTPM
- appendix: 0.2 nTPM
- breast: 0.1 nTPM
- cerebellum: 0.1 nTPM
- heart muscle: 0.1 nTPM
Single-cell type
- late spermatids: 5,701 nCPM
- early spermatids: 1,920 nCPM
- late primary spermatocytes: 419 nCPM
- sertoli cells: 15 nCPM
- leydig cells: 9.9 nCPM
- early primary spermatocytes: 5.7 nCPM
Immune cell
- eosinophil: 0.1 nTPM
- NK-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- white matter: 0.7 nTPM
- cerebellum: 0.6 nTPM
- medulla oblongata: 0.6 nTPM
- cerebral cortex: 0.5 nTPM
- hippocampal formation: 0.5 nTPM
- pons: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.81
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
OntologyGO
Biological processes
Molecular functions
- ATP binding
- magnesium ion binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- protein-containing complex binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TSSK2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSSK2 as an antibody target. Whether an autoantibody or antibody against TSSK2 could matter depends on whether native TSSK2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSSK2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TSSK2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...